(Q27860650)
Statements
Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma (English)
0 references
11 July 2013
0 references
369
0 references
134-44
0 references
2
0 references
scientific article (publication date: 11 July 2013)